Blundell is Professor Emeritus and Director of Research in Biochemistry, Cambridge, UK, having been Professor of Biochemistry and Head, School of Biological Sciences, until 2009. He obtained D.Phil at Oxford University in 1967, and held positions at Oxford, Sussex and London before moving to Cambridge in 1996. He is a member of Academia Europaea; Fellow of Royal Society, Academy of Medical Sciences, Indian Natl. Academy of Science and Chilean National Academy; and has hon. doctorates from 16 universities. He was member of advisory group to Prime Minister; founding CEO, Biotechnology and Biological Sciences Research Council; Chair, Royal Commission Environmental Pollution; President, Biosciences Fed., Biochemical Society and Science Council. He co-founded Astex Pharma, sold recently for USD886M.